Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.

Said E, Said SA, Elkashef WF, Gameil NM, Ammar EM.

Inflammopharmacology. 2012 Apr;20(2):77-87. doi: 10.1007/s10787-011-0117-1. Epub 2012 Jan 26.

PMID:
22278738
2.

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.

El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA.

Parasit Vectors. 2012 Jan 11;5:9. doi: 10.1186/1756-3305-5-9.

3.

Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.

El-Lakkany NM, El-Maadawy W, Ain-Shoka A, Badawy A, Hammam O, Ebeid F.

Clin Exp Pharmacol Physiol. 2011 Oct;38(10):695-704. doi: 10.1111/j.1440-1681.2011.05575.x.

PMID:
21762203
4.

Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.

Rahoud SA, Mergani A, Khamis AH, Saeed OK, Mohamed-Ali Q, Dessein AJ, Elwali NE.

FEMS Immunol Med Microbiol. 2010 Feb;58(1):106-12. doi: 10.1111/j.1574-695X.2009.00640.x. Epub 2009 Nov 30.

5.

Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.

Elsakkar MG, Eissa MM, Hewedy WA, Nassra RM, Elatrebi SF.

Life Sci. 2016 Oct 1;162:95-101. doi: 10.1016/j.lfs.2016.08.010. Epub 2016 Aug 12.

PMID:
27528511
6.

Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.

Sharaf El-Deen SA, Brakat RM, Mohamed ASED.

Exp Parasitol. 2017 Jul;178:51-59. doi: 10.1016/j.exppara.2017.05.005. Epub 2017 May 25.

PMID:
28552793
7.

Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.

Attia YM, Elalkamy EF, Hammam OA, Mahmoud SS, El-Khatib AS.

Parasit Vectors. 2013 Jul 5;6:199. doi: 10.1186/1756-3305-6-199.

8.

Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.

El-Agamy DS, Shebl AM, Said SA.

Inflammopharmacology. 2011 Dec;19(6):307-16. doi: 10.1007/s10787-011-0092-6. Epub 2011 Sep 23.

PMID:
21947519
9.

Improvement of the liver pathology by the aqueous extract and the n-butanol fraction of Sida pilosa Retz in Schistosoma mansoni-infected mice.

Jatsa HB, Russo RC, Pereira CA, Aguilar EC, Garcia CC, Araújo ES, Oliveira JL, Rodrigues VF, de Oliveira VG, Alvarez-Leite JI, Braga FC, Louis-Albert Tchuem Tchuente, Kamtchouing P, Negrão-Corrêa DA, Teixeira MM.

J Ethnopharmacol. 2016 Mar 2;180:114-23. doi: 10.1016/j.jep.2016.01.017. Epub 2016 Jan 19.

PMID:
26806570
10.

The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice.

Mahmoud MR, El-Abhar HS, Saleh S.

J Ethnopharmacol. 2002 Jan;79(1):1-11.

PMID:
11744288
11.

The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni.

El-Lakkany N, el-Din SS, Ebeid F.

Exp Parasitol. 2011 Oct;129(2):152-7. doi: 10.1016/j.exppara.2011.06.015. Epub 2011 Jul 6.

PMID:
21762692
12.

Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Mola PW, Farah IO, Kariuki TM, Nyindo M, Blanton RE, King CL.

Infect Immun. 1999 Dec;67(12):6565-71.

13.

Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.

el-Shafei MM, Mattar MA, Afify HA.

J Egypt Soc Parasitol. 2002 Aug;32(2):551-60.

PMID:
12214932
14.

Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

J Helminthol. 2002 Dec;76(4):327-33.

PMID:
12498638
15.

The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.

Helmy AH, Abdel-Hady AA, el-Shanawany F, Hammam O, Abdel-Hady A.

J Egypt Soc Parasitol. 2005 Dec;35(3):731-50.

PMID:
16333884
16.

Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.

Botros SS, Hammam O, Mahmoud M, Bergquist R.

APMIS. 2010 Sep 1;118(9):692-702. doi: 10.1111/j.1600-0463.2010.02645.x.

PMID:
20718722
17.

The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.

Mohamed AH, Osman GY, Salem TA, Elmalawany AM.

Exp Parasitol. 2014 Oct;145:7-13. doi: 10.1016/j.exppara.2014.06.016. Epub 2014 Jul 10.

PMID:
25016189
18.

Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection.

Koslowski N, Sombetzki M, Loebermann M, Engelmann R, Grabow N, Österreicher CH, Trauner M, Mueller-Hilke B, Reisinger EC.

PLoS Negl Trop Dis. 2017 May 19;11(5):e0005595. doi: 10.1371/journal.pntd.0005595. eCollection 2017 May.

19.

Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress.

Al-Olayan EM, El-Khadragy MF, Alajmi RA, Othman MS, Bauomy AA, Ibrahim SR, Abdel Moneim AE.

BMC Complement Altern Med. 2016 Nov 8;16(1):434. Erratum in: BMC Complement Altern Med. 2017 Jan 17;17 (1):51.

20.

Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.

Manneck T, Haggenmüller Y, Keiser J.

Parasitology. 2010 Jan;137(1):85-98. doi: 10.1017/S0031182009990965. Epub 2009 Oct 9.

PMID:
19814844

Supplemental Content

Support Center